{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:24:04Z","timestamp":1791645844922,"version":"4.3.4"},"reference-count":173,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.autrev.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T16:39:02Z","timestamp":1533919142000},"page":"1053-1064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"title":["Clinical and immunological parameters of Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"17","author":[{"given":"Konstantia","family":"Psianou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Panagoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios D.","family":"Papanastasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"de Lastic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota I.","family":"Spantidea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren E.","family":"Degn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Mouzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1034\/j.1601-0825.2002.02846.x","article-title":"Current issues in Sjogren's syndrome","volume":"8","author":"Jonsson","year":"2002","journal-title":"Oral Dis"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12663-011-0303-0","article-title":"Sj\u00f6gren's before Sj\u00f6gren: did Henrik Sj\u00f6gren (1899-1986) really discover Sj\u00f6gren's disease?","volume":"11","author":"Ghafoor","year":"2012","journal-title":"J Maxillofac Oral Surg"},{"key":"10.1016\/j.autrev.2018.05.005_bb0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00005792-196505000-00001","article-title":"Sjoegren's syndrome. A clinical, pathological, and serological study of sixty-two cases","volume":"44","author":"Bloch","year":"1965","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jcp.21.5.656","article-title":"Labial salivary gland biopsy in Sj\u00f6gren's disease","volume":"21","author":"Chisholm","year":"1968","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/path.1700910107","article-title":"Post-mortem prevalence of focal lymphocytic adenitis of the submandibular salivary gland","volume":"91","author":"Waterhouse","year":"1966","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.autrev.2018.05.005_bb0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.01.013","article-title":"Classification criteria of Sj\u00f6gren's syndrome","volume":"48\u201349","author":"Goules","year":"2014","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0035","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.1780360309","article-title":"Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community","volume":"36","author":"Vitali","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0040","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2018.05.005_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2011.12.006","article-title":"Classification criteria for Sjogren's syndrome: a critical review","volume":"39","author":"Baldini","year":"2012","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sj\u00f6gren's syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren's international collaborative clinical alliance cohort","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0060","doi-asserted-by":"crossref","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","article-title":"The geoepidemiology of Sj\u00f6gren's syndrome","volume":"9","author":"Mavragani","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0065","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.39560","article-title":"X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and Sj\u00f6gren's syndrome","volume":"68","author":"Liu","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0070","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/annrheumdis-2016-209952","article-title":"Influence of geolocation and ethnicity on the phenotypic expression of primary Sj\u00f6gren's syndrome at diagnosis in 8310 patients: a cross sectional study from the big data Sj\u00f6gren project consortium","volume":"76","author":"Brito-Zer\u00f3n","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/BOR.0b013e328363ed23","article-title":"Childhood Sj\u00f6gren syndrome: insights from adults and animal models","volume":"25","author":"Lieberman","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0080","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/154405910808700411","article-title":"Oral manifestations of Sj\u00f6gren's syndrome","volume":"87","author":"Mathews","year":"2008","journal-title":"J Dent Res"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4081\/reumatismo.2011.97","article-title":"Primary Sj\u00f6gren syndrome: report of a 10 years old girl with local edema and positivity of anti SS-A and anti SS-B autoantibodies","volume":"63","author":"Shahi","year":"2011","journal-title":"Reumatismo"},{"issue":"9482","key":"10.1016\/j.autrev.2018.05.005_bb0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren's syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2018.05.005_bb0095","series-title":"Insights and perspectives in rheumatology","isbn-type":"print","first-page":"123","article-title":"Diagnostic and prognostic features of Sj\u00f6gren's syndrome","author":"Soyfoo","year":"2012","ISBN":"https:\/\/id.crossref.org\/isbn\/9789533078465"},{"issue":"9","key":"10.1016\/j.autrev.2018.05.005_bb0100","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.autrev.2017.07.012","volume":"16","author":"Giacomelli","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0105","article-title":"Diagnostic approaches to Sj\u00f6gren's syndrome: a literature review and own clinical experience","volume":"3","author":"Gomes Pde","year":"2012","journal-title":"J Oral Maxillofac Res"},{"issue":"10","key":"10.1016\/j.autrev.2018.05.005_bb0110","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sj\u00f6gren's syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0115","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sj\u00f6gren's syndrome: a prospective cohort study","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0120","first-page":"450","article-title":"Rate, risk factors and causes of mortality in patients with Sj\u00f6gren'ssyndrome: a systemic review and meta-analysis of cohort studies","volume":"55","author":"Singh","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.05.005_bb0125","first-page":"254319","article-title":"Introducing polyautoimmunity: secondary autoimmune diseases no longer exist","volume":"2012","author":"Rojas-Villarraga","year":"2012","journal-title":"Autoimmune Dis"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.autrev.2016.01.013","article-title":"Sj\u00f6gren's syndrome and multiple sclerosis: two sides of the same coin?","volume":"15","author":"Masi","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaut.2012.05.008","article-title":"Sj\u00f6gren's syndrome at the crossroad of polyautoimmunity","volume":"39","author":"Amador-Patarroyo","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.05.005_bb0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fendo.2018.00121","article-title":"The association of Sj\u00f6gren syndrome and autoimmune thyroid disorders","volume":"9","author":"Baldini","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/ard.59.3.230","article-title":"Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus","volume":"59","author":"McDonagh","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/0961203309348235","article-title":"Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study","volume":"19","author":"Xu","year":"2010","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0155","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3899\/jrheum.090804","article-title":"Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset","volume":"37","author":"Baer","year":"2010","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2018.05.005_bb0160","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.humimm.2006.06.006","article-title":"Clinical, serologic, and genetic profiles of patients with associated Sj\u00f6gren's syndrome and systemic lupus erythematosus","volume":"67","author":"Szanto","year":"2006","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.autrev.2017.02.010","article-title":"Neonatal lupus: follow-up in infants with anti-SSA\/Ro antibodies and review of the literature","volume":"16","author":"Zuppa","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.autrev.2016.12.004","article-title":"Anti-RO\/SSA and anti-La\/SSB antibodies: association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus","volume":"16","author":"Novak","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0175","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaut.2008.05.002","article-title":"Polyautoimmunity and familial autoimmunity in systemic sclerosis","volume":"31","author":"Hudson","year":"2008","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.autrev.2018.05.005_bb0180","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.autrev.2013.05.002","article-title":"Systemic sclerosis at the crossroad of polyautoimmunity","volume":"12","author":"Elhai","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0185","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.autrev.2016.12.006","article-title":"Sj\u00f6gren's syndrome-associated myositis with germinal Centre-like structures","volume":"16","author":"Espitia-Thibault","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-0404.2010.01428.x","article-title":"Clinical features of Sjogren's syndrome in patients with multiple sclerosis","volume":"124","author":"Annunziata","year":"2011","journal-title":"Acta Neurol Scand"},{"issue":"12","key":"10.1016\/j.autrev.2018.05.005_bb0195","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.autrev.2016.09.009","article-title":"The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients","volume":"15","author":"Fallahi","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","article-title":"Interstitial lung disease in primary Sj\u00f6gren's syndrome","volume":"16","author":"Roca","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2018.05.005_bb0205","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrrheum.2010.118","article-title":"Pathogenetic mechanisms in the initiation and perpetuation of Sj\u00f6gren's syndrome","volume":"6","author":"Voulgarelis","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2018.05.005_bb0210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1834-7819.2010.01197.x","article-title":"Sj\u00f6gren's syndrome: a review of aetiology, pathogenesis, diagnosis and management","volume":"55","author":"Bayetto","year":"2010","journal-title":"Aust Dent J"},{"issue":"9894","key":"10.1016\/j.autrev.2018.05.005_bb0215","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","article-title":"Immunopathogenic mechanisms of systemic autoimmune disease","volume":"382","author":"Wahren-Herlenius","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.autrev.2018.05.005_bb0220","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren's syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaut.2010.06.012","article-title":"Activation of the type I interferon pathway in primary Sjogren's syndrome","volume":"35","author":"Mavragani","year":"2010","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0230","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/gene.2008.94","article-title":"Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome","volume":"10","author":"Nordmark","year":"2009","journal-title":"Genes Immun"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0235","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/sji.12101","article-title":"Association of genes in the NF-\u03baB pathway with antibody-positive primary Sj\u00f6gren's syndrome","volume":"78","author":"Nordmark","year":"2013","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0240","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12016-007-8004-7","article-title":"Persistent viral infection in primary Sjogren's syndrome: review and perspectives","volume":"32","author":"Triantafyllopoulou","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2018.05.005_bb0245","doi-asserted-by":"crossref","first-page":"535738","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases","volume":"2013","author":"Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2018.05.005_bb0250","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38726","article-title":"Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sj\u00f6gren's syndrome","volume":"66","author":"Croia","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.05.005_bb0255","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2014.02.008","article-title":"(2014) infection and autoimmunity in Sjogren's syndrome: a clinical study and comprehensive review","volume":"51","author":"Kivity","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.05.005_bb0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1741-7015-11-93","article-title":"Novel aspects of Sj\u00f6gren's syndrome in 2012","volume":"11","author":"Tincani","year":"2013","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0265","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jaut.2012.05.018","article-title":"Low levels of vitamin D are associated with neuropathy and lymphoma among patients with Sj\u00f6gren's syndrome","volume":"39","author":"Agmon-Levin","year":"2012","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0270","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.autrev.2017.04.004","article-title":"Vitamin D and Sj\u00f6gren syndrome","volume":"16","author":"Garcia-Carrasco","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0275","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/annrheumdis-2011-200207","article-title":"Development of heart block in children of SSA\/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern","volume":"71","author":"Ambrosi","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0280","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/s10165-011-0446-3","article-title":"Cigarette smoking in primary Sj\u00f6gren's syndrome: positive association only with ANA positivity","volume":"21","author":"Karabulut","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0285","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.2007.084152","article-title":"Stress, coping strategies and social support in patients with primary Sjogren's syndrome prior to disease onset: a retrospective case-control study","volume":"68","author":"Karaiskos","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2018.05.005_bb0290","first-page":"1508","article-title":"Hypofunction of the stress axis in Sjogren's syndrome","volume":"25","author":"Johnson","year":"1998","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0295","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1601-0825.2011.01866.x","article-title":"Sialochemistry and cortisol levels in patients with Sjogren's syndrome","volume":"18","author":"Miller","year":"2012","journal-title":"Oral Dis"},{"key":"10.1016\/j.autrev.2018.05.005_bb0300","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/acr.20022","article-title":"Dehydroepiandrosterone (DHEA) substitution treatment for severe fatigue in DHEA-deficient patients with primary Sjogren's syndrome","volume":"62","author":"Virkki","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0305","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/03009742.2011.580000","article-title":"Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sjogren's syndrome","volume":"40","author":"Porola","year":"2011","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0310","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jaut.2012.05.011","article-title":"Endocrine alterations in primary Sjogren's syndrome: an overview","volume":"39","author":"Mavragani","year":"2012","journal-title":"J Autoimmun"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2018.05.005_bb0315","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaut.2012.01.005","article-title":"The salivary gland epithelial cells of patients with primary Sjogren's syndrome manifest significantly reduced responsiveness to 17beta-estradiol","volume":"39","author":"Manoussakis","year":"2012","journal-title":"J Autoimmun"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2018.05.005_bb0320","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2012.01.004","article-title":"Sex steroids in Sj\u00f6gren's syndrome","volume":"39","author":"Konttinen","year":"2012","journal-title":"J Autoimmun"},{"issue":"6\u20137","key":"10.1016\/j.autrev.2018.05.005_bb0325","doi-asserted-by":"crossref","first-page":"A465","DOI":"10.1016\/j.autrev.2011.11.009","article-title":"Prolactin and autoimmunity","volume":"11","author":"Shelly","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0330","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/RHU.0b013e3181d52a28","article-title":"Autoimmune thyroid disease and Sjogren syndrome","volume":"16","author":"Alfaris","year":"2010","journal-title":"J Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0335","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/acr.20117","article-title":"Functional impairment of the arterial wall in primary Sj\u00f6gren's syndrome: combined action of immunologic and inflammatory factors","volume":"62","author":"Gerli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0340","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cyto.2012.12.021","article-title":"Emerging avenues linking inflammation, angiogenesis and Sj\u00f6gren's syndrome","volume":"61","author":"Lisi","year":"2013","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0345","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/rheumatology\/keu320","article-title":"Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sj\u00f6gren's syndrome: new markers of chronic endothelial damage?","volume":"54","author":"Bartoloni","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0350","first-page":"746","article-title":"Risk of venous thromboembolism in patients with Sj\u00f6gren's syndrome: a systematic review and meta-analysis","volume":"33","author":"Ungprasert","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0355","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/gene.2012.9","article-title":"Sj\u00f6gren's syndrome pathological neovascularization is regulated by VEGF-Astimulated TACE-dependent crosstalk between VEGFR2 and NF-\u03baB","volume":"13","author":"Sisto","year":"2012","journal-title":"Genes Immun"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0360","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00418-012-0910-y","article-title":"Neuropilin-1 is upregulated in Sjogren's syndrome and contributes to pathological neovascularization","volume":"137","author":"Sisto","year":"2012","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0365","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2249.2012.04606.x","article-title":"Selective localization of T helper subsets in labial salivary glands from primary Sj\u00f6gren's syndrome patients","volume":"169","author":"Maehara","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0370","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2249.2002.01869.x","article-title":"The Th1\/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome","volume":"128","author":"Mitsias","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0375","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3083.2010.02432.x","article-title":"Effector and regulatory T cell subsets in autoimmunity and tissue inflammation","volume":"72","author":"Jager","year":"2010","journal-title":"Scand J Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0380","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/rheumatology\/keq328","article-title":"FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th17 cells","volume":"50","author":"Abdulahad","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0385","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/sji.12622","article-title":"Patients with primary Sj\u00f6gren's syndrome have alterations in absolute quantities of specific peripheral leucocyte populations","volume":"86","author":"Davies","year":"2017","journal-title":"Scand J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0390","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","article-title":"Th17 cells play a critical role in the development of experimental Sj\u00f6gren's syndrome","volume":"74","author":"Lin","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0395","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2013.02.024","article-title":"Follicular helper T cells may play an important role in the severity of primary Sj\u00f6gren's syndrome","volume":"147","author":"Szabo","year":"2013","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0400","first-page":"1988","article-title":"CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome","volume":"7","author":"Jin","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0405","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaut.2005.01.015","article-title":"CD4 CD25high regulatory T cells are not impaired in patients with primary Sj\u00f6gren's syndrome","volume":"24","author":"Gottenberg","year":"2005","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0410","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/0961203309348234","article-title":"The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sj\u00f6gren's syndrome","volume":"19","author":"Sarigul","year":"2010","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0415","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2353\/ajpath.2008.080246","article-title":"Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors","volume":"173","author":"Christodoulou","year":"2008","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.autrev.2018.05.005_bb0420","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/rheumatology\/ket179","article-title":"Characterization of a new regulatory CD4+ T cell subset in primary Sj\u00f6gren's syndrome","volume":"52","author":"Alunno","year":"2013","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.autrev.2018.05.005_bb0425","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/eji.201040943","article-title":"CD4+CD25lowGITR+ cells: a novel human CD4+ T-cell population with regulatory activity","volume":"41","author":"Bianchini","year":"2011","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0430","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/annrheumdis-2012-201511","article-title":"IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome","volume":"72","author":"Alunno","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2018.05.005_bb0435","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1385\/IR:35:1:163","article-title":"Double-negative regulatory T cells: non-conventional regulators","volume":"35","author":"Thomson","year":"2006","journal-title":"Immunol Res"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0440","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.smim.2011.04.003","article-title":"Making sense of regulatory T cell suppressive function","volume":"23","author":"Shalev","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2018.05.005_bb0445","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2014.01.030","article-title":"CD4-CD8- T-cells in primary Sj\u00f6gren's syndrome: association with the extent of glandular involvement","volume":"51","author":"Alunno","year":"2014","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0450","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1542-0124(12)70289-6","article-title":"Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease","volume":"7","author":"Nguyen","year":"2009","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0455","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2012.05.014","article-title":"B cells in Sj\u00f6gren's syndrome: from pathophysiology to diagnosis and treatment","volume":"39","author":"Cornec","year":"2012","journal-title":"J Autoimmun"},{"issue":"8","key":"10.1016\/j.autrev.2018.05.005_bb0460","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sj\u00f6gren's syndrome: a multicenter, retrospective, clinical study by the European concerted action on Sj\u00f6gren's syndrome","volume":"42","author":"Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2018.05.005_bb0465","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sj\u00f6gren's syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.05.005_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2018.02.003","article-title":"Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sj\u00f6gren's syndrome","author":"Navarro-Mendoza","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2018.05.005_bb0475","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/ard.2008.096172","article-title":"Is the blood B-cell subset profile diagnostic for Sjogren syndrome?","volume":"68","author":"Binard","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2018.05.005_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114575","article-title":"Accumulation of self-reactive na\u00efve and memory B cell reveals sequential defects in B cell tolerance checkpoints in Sj\u00f6gren's syndrome","volume":"9","author":"Corsiero","year":"2014","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.autrev.2018.05.005_bb0485","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/art.38734","article-title":"Primary Sj\u00f6gren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells","volume":"66","author":"Roberts","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0490","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/eji.200424856","article-title":"Frontline: optimal T cell activation requires the engagement of CD6 and CD166","volume":"34","author":"Hassan","year":"2004","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0495","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaut.2010.07.005","article-title":"Aberrant expression of CD6 on B-cell subsets from patients with Sj\u00f6gren's syndrome","volume":"35","author":"Alonso","year":"2010","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0500","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0505","first-page":"157","article-title":"Practical usefulness of IgA-containing immune complex determination in the serum of patients with primary Sj\u00f6gren's syndrome","volume":"15","author":"Basset","year":"1997","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2018.05.005_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112100","article-title":"Impaired clearance of early apoptotic cells mediated by inhibitory IgG antibodies in patients with primary Sj\u00f6gren's syndrome","volume":"9","author":"Manoussakis","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2018.05.005_bb0515","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaut.2012.03.001","article-title":"Subgroups of Sj\u00f6gren syndrome patients according to serological profiles","volume":"39","author":"Bournia","year":"2012","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0520","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10067-005-0059-3","article-title":"Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sj\u00f6gren's syndrome: prevalence and clinical significance in 335 patients","volume":"25","author":"Nardi","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2018.05.005_bb0525","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2012.01.014","article-title":"The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review","volume":"39","author":"Oke","year":"2012","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0530","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.autrev.2016.01.008","article-title":"Secreted autoantibody repertoires in Sj\u00f6gren's syndrome and systemic lupus erythematosus: a proteomic approach","volume":"15","author":"Al Kindi","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0535","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10067-011-1789-z","article-title":"Clinical significance and diagnostic usefulness of anti-centromere antibody in Sj\u00f6gren's syndrome","volume":"31","author":"Kitagawa","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"24","key":"10.1016\/j.autrev.2018.05.005_bb0540","doi-asserted-by":"crossref","first-page":"7834","DOI":"10.1021\/jm800891n","article-title":"Citrullination of linear and cyclic altered peptide ligands from myelin basic protein (MBP87-99) epitope elicits a Th1 polarized response by T cells isolated from multiple sclerosis patients: implications in triggering disease","volume":"51","author":"Deraos","year":"2008","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0545","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3899\/jrheum.080193","article-title":"Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies","volume":"36","author":"Iwamoto","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.05.005_bb0550","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","article-title":"A comprehensive review of autoantibodies in primary Sj\u00f6gren's syndrome: clinical phenotypes and regulatory mechanisms","volume":"51","author":"Kyriakidis","year":"2014","journal-title":"J Autoimmun"},{"issue":"7\u20138","key":"10.1016\/j.autrev.2018.05.005_bb0555","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cca.2010.12.019","article-title":"Disease-specific autoantibodies in primary biliary cirrhosis","volume":"412","author":"Bogdanos","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0560","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/s10165-012-0788-5","article-title":"Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sj\u00f6gren's syndrome","volume":"23","author":"Sumida","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0565","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/rheumatology\/keh506","article-title":"Hydroxychloroquine therapy in patients with primary Sj\u00f6gren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase","volume":"44","author":"Dawson","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0570","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.molimm.2013.06.004","article-title":"The inhibitory effects of antimuscarinic autoantibodies in the sera of primary Sjogren syndrome patients on the gastrointestinal motility","volume":"56","author":"Park","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2018.05.005_bb0575","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.12.012","article-title":"The role of M3 muscarinic acetylcholine receptor reactive T cells in Sj\u00f6gren's syndrome: a critical review","volume":"51","author":"Sumida","year":"2014","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0580","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.archoralbio.2010.08.017","article-title":"Anti-M(3) muscarinic cholinergic autoantibodies from patients with primary Sj\u00f6gren's syndrome trigger production of matrix metalloproteinase-3 (MMP-3) and prostaglandin E(2) (PGE(2)) from the submandibular glands","volume":"56","author":"Reina","year":"2011","journal-title":"Arch Oral Biol"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0585","first-page":"1034","article-title":"Novel autoantibodies in Sjogren's syndrome","volume":"4","author":"Sandhu","year":"2017","journal-title":"J Immunol Clin Res"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0590","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/03009740801910361","article-title":"Immunological alterations in newly diagnosed primary Sj\u00f6gren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines","volume":"37","author":"Szodoray","year":"2008","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0595","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2249.2012.04587.x","article-title":"Cytokine\/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sj\u00f6gren's syndrome","volume":"169","author":"Moriyama","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0600","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajo.2013.04.003","article-title":"Analysis of tear cytokines and clinical correlations in Sj\u00f6gren syndrome dry eye patients and non-Sj\u00f6gren syndrome dry eye patients","volume":"156","author":"Lee","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0605","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clim.2005.06.016","article-title":"Distinct profiles of Sj\u00f6gren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF","volume":"117","author":"Szodoray","year":"2005","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0610","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.4049\/jimmunol.152.11.5532","article-title":"Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome","volume":"152","author":"Fox","year":"1994","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0615","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jop.12149","article-title":"Th1 and Th2 polymorphisms in Sj\u00f6gren's syndrome and rheumatoid arthritis","volume":"43","author":"de Souza","year":"2014","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2018.05.005_bb0620","doi-asserted-by":"crossref","first-page":"187258","DOI":"10.1155\/2012\/187258","article-title":"Expression of IL-17, IL-23 and their receptors in minor salivary glands of patients with primary Sjogren's syndrome","volume":"2012","author":"Mieliauskaite","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0625","first-page":"51399","article-title":"Serum interleukin-17 & nitric oxide levels in patients with primary Sjogren's syndrome","volume":"135","author":"Miletic","year":"2012","journal-title":"Indian J Med Res"},{"issue":"7","key":"10.1016\/j.autrev.2018.05.005_bb0630","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3346\/jkms.2011.26.7.938","article-title":"Interleukin-17 in various ocular surface inflammatory disea Interleukin-17 in various ocular surface inflammatory diseases","volume":"26","author":"Kang","year":"2011","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0635","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-3083.2011.02583.x","article-title":"Expression of Interleukin-22 in Sj\u00f6gren's syndrome: significant correlation with disease parameters","volume":"74","author":"Lavoie","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2018.05.005_bb0640","doi-asserted-by":"crossref","unstructured":"Pan HF, Li XP, Zheng SG, Ye DQ. Emerging role of interleukin-22 in autoimmune diseases. Cytokine Growth Factor Rev;24(1):51\u20137.","DOI":"10.1016\/j.cytogfr.2012.07.002"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0645","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/cei.12643","article-title":"Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sj\u00f6gren-associated non-Hodgkin lymphomas and is regulated by IL-18","volume":"181","author":"Ciccia","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0650","first-page":"970","article-title":"Salivary cytokine profiles in primary Sjogren's syndrome differ from those in non-Sjogren sicca in terms of TNF-\u03b1 levels and Th-1\/Th-2 ratios","volume":"29","author":"Kang","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2018.05.005_bb0655","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/art.38007","article-title":"Interleukin-7 enhances the Th1 response to promote the development of Sj\u00f6gren's syndrome-like autoimmune exocrinopathy in mice","volume":"65","author":"Jin","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.05.005_bb0660","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13075-015-0582-9","article-title":"Altered balance of interleukin-13\/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sj\u00f6gren's syndrome","volume":"17","author":"Bian","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0665","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/08830185.2016.1276903","article-title":"Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases","volume":"36","author":"Samy","year":"2017","journal-title":"Int Rev Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0670","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sj\u00f6gren's syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0675","first-page":"1281","article-title":"Lacrimal gland inflammation is responsible for ocular pathology in TGF-beta 1 null mice","volume":"151","author":"McCartney-Francis","year":"1997","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0680","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.pharmthera.2013.03.003","article-title":"Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases","volume":"138","author":"Li","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0685","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.tripleo.2010.01.006","article-title":"Expression of toll-like receptors 7, 8, and 9 in primary Sjogren's syndrome","volume":"109","author":"Zheng","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0690","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.smim.2006.12.003","article-title":"What is the role of toll-like receptors in bacterial infections?","volume":"19","author":"Gerold","year":"2007","journal-title":"Semin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0695","first-page":"1019","article-title":"oll-like receptor in salivary glands from patients with Sjogren's syndrome: functional analysis by human salivary gland cell line","volume":"34","author":"Kawakami","year":"2007","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2018.05.005_bb0700","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2012.53","article-title":"Topical and systemic medications for the treatment of primary Sj\u00f6gren's syndrome","volume":"8","author":"Ramos-Casals","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0705","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.berh.2012.01.012","article-title":"Sj\u00f6gren's syndrome, the old and the new","volume":"26","author":"Peri","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0710","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/1759720X10363246","article-title":"Treating Sj\u00f6gren's syndrome: insights for the clinician","volume":"2","author":"Vitali","year":"2010","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0715","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/art.27766","article-title":"Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial","volume":"63","author":"Strietzel","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.05.005_bb0720","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/OPTH.S150957","article-title":"Topical ocular 0.1% cyclosporine a cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program","volume":"12","author":"Pisella","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"10.1016\/j.autrev.2018.05.005_bb0725","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/ICO.0000000000000155","article-title":"Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sj\u00f6gren syndrome patients with or without punctal occlusions","volume":"33","author":"Arimoto","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.autrev.2018.05.005_bb0730","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000131089","article-title":"Eyelid botulinum toxin injections for the dry eye","volume":"41","author":"Sahlin","year":"2008","journal-title":"Dev Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0735","doi-asserted-by":"crossref","first-page":"931","DOI":"10.21873\/invivo.11016","article-title":"Effect of autologous serum eye drops in patients with Sj\u00f6gren syndrome-related dry eye: clinical and in vivo confocal microscopy evaluation of the ocular surface","volume":"30","author":"Semeraro","year":"2016","journal-title":"In Vivo"},{"key":"10.1016\/j.autrev.2018.05.005_bb0740","article-title":"Autologous serum eye drops for dry eye","volume":"2","author":"Pan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0745","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.rbr.2015.07.004","article-title":"Recommendations for the treatment of Sj\u00f6gren's syndrome","volume":"55","author":"Valim","year":"2015","journal-title":"Rev Bras Reumatol"},{"issue":"5","key":"10.1016\/j.autrev.2018.05.005_bb0750","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.autrev.2018.03.003","article-title":"Optimizing conventional DMARD therapy for Sj\u00f6gren's syndrome","volume":"17","author":"van der Heijden","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0755","first-page":"179","article-title":"One year in review 2017: primary Sjogrens syndrome","volume":"35","author":"Ferro","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2018.05.005_bb0760","article-title":"Biologic agents in systemic dermatotherapy: cutaneous and systemic side e","author":"Badavanis","year":"2017","journal-title":"Curr Drug Saf"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0765","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1067\/mlc.2002.120648","article-title":"Regulation of apoptotic cell death by cytokines in a human salivary gland cell line: distinct and synergistic mechanisms in apoptosis induced by tumor necrosis factor alpha and interferon gamma","volume":"139","author":"Kamachi","year":"2002","journal-title":"J Lab Clin Med"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0770","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0003-9969(02)00025-0","article-title":"Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha","volume":"47","author":"McArthur","year":"2002","journal-title":"Arch Oral Biol"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0775","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0780","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gpb.2015.06.002","article-title":"Biomarkers for primary Sjogren's syndrome","volume":"13","author":"Chen","year":"2015","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2018.05.005_bb0785","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.molimm.2011.08.012","article-title":"Contribution of IL-13 to early exocrinopathy in Id3\u2212\/\u2212 mice","volume":"49","author":"Mahlios","year":"2011","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0790","first-page":"63","article-title":"Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjogren's syndrome","volume":"16","author":"Skopouli","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2018.05.005_bb0795","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaut.2017.11.003","article-title":"Th17 cells in primary Sjogren's syndrome: pathogenicity and plasticity","volume":"87","author":"Verstappen","year":"2018","journal-title":"J Autoimmun"},{"issue":"35","key":"10.1016\/j.autrev.2018.05.005_bb0800","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1073\/pnas.1503315112","article-title":"IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs","volume":"112","author":"Barone","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2018.05.005_bb0805","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2013.11.003","article-title":"Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjogren's syndrome","volume":"51","author":"Gong","year":"2014","journal-title":"J Autoimmun"},{"issue":"9","key":"10.1016\/j.autrev.2018.05.005_bb0810","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/art.40165","article-title":"Attenuation of follicular helper T cell-dependent B cell hyperactivity by Abatacept treatment in primary Sjogren's syndrome","volume":"69","author":"Verstappen","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2018.05.005_bb0815","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/art.37850","article-title":"Rituximab therapy for primary Sj\u00f6gren's syndrome: an open-label clinical trial and mechanistic analysis","volume":"65","author":"St. Clair","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0820","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","article-title":"Efficacy of rituximab in systemic manifestations of primary Sj\u00f6gren's syndrome: results in 78 patients of the autoimmune and rituximab registry","volume":"72","author":"Gottenberg","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2018.05.005_bb0825","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","article-title":"Efficacy and safety of belimumab in primary Sj\u00f6gren's syndrome: results of the BELISS open-label phase II study","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2018.05.005_bb0830","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.molimm.2006.05.007","article-title":"Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab","volume":"44","author":"Carnahan","year":"2007","journal-title":"Mol Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2018.05.005_bb0835","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/acr.22052","article-title":"Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sj\u00f6gren's syndrome: a pilot study","volume":"65","author":"Adler","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.autrev.2018.05.005_bb0840","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","article-title":"Abatacept treatment reduces disease activity in early primary Sj\u00f6gren's syndrome (open-label proof of concept ASAP study)","volume":"73","author":"Meiners","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 10","key":"10.1016\/j.autrev.2018.05.005_bb0845","first-page":"2538","article-title":"The novel anti-CD40 monoclonal antibody CFZ533 shows beneficial effects in patients with primary Sj\u00f6gren's syndrome: a phase IIa double-blind, placebo-controlled randomized trial","volume":"69","author":"Fisher","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"suppl.1","key":"10.1016\/j.autrev.2018.05.005_bb0850","doi-asserted-by":"crossref","first-page":"A58","DOI":"10.1136\/annrheumdis-2016-209124.138","article-title":"Phosphatidylinositol 3\u2013kinase delta pathway a novel therapeutic target for sjoegren's syndrome","volume":"75","author":"Nayar","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2018.05.005_bb0855","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/RHU.0000000000000210","article-title":"Refractory primary Sj\u00f6gren syndrome successfully treated with bortezomib","volume":"21","author":"Jakez-Ocampo","year":"2015","journal-title":"J Clin Rheumatol"},{"issue":"15","key":"10.1016\/j.autrev.2018.05.005_bb0860","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2018.05.005_bb0865","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/cei.12868","article-title":"ROR\u03b3t antagonist suppresses M3 muscarinicacetylcholine receptor-induced Sj\u00f6gren's syndrome-like sialadenitis","volume":"187","author":"Tahara","year":"2017","journal-title":"Clin Exp Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218301885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218301885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T08:57:49Z","timestamp":1751792269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218301885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":173,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1568997218301885"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.05.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and immunological parameters of Sj\u00f6gren's syndrome","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}